Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Viveve Medical Inc VIVE

Viveve Medical, Inc. designs, develops, manufactures and markets a platform medical technology, Cryogen-cooled Monopolar RadioFrequency (CMRF). The Company’s CMRF technology is delivered through a radiofrequency generator, handpiece and treatment tip, which collectively, is referred to as the Viveve System. The Viveve System is marketed for the non-invasive treatment of vaginal introital laxity... see more

GREY:VIVE - Post Discussion

Viveve Medical Inc > Price drops?
View:
Post by EquityGuy219 on Apr 05, 2019 11:42am

Price drops?

Does anyone have insight into the recent price drops (essentially from $1 to $0.80)?  I am not seeing any news that would justify it.  Even some of the price target slashes are down to $3, still a tremendous upside yet the slide down continues. Thank you in advance!
Comment by dmacd on Apr 05, 2019 2:31pm
Great technology and development roll out. Main issue is management have been disrespectful to its shareholders with massive dilution and the cash bleed has no end in sight. Once it goes cash flow positive the SP will drive up. Losses must taper and sales cannot have slowed in Q1 after the restructure. The SP suggests investor expectations are not being achieved. If do then it will be time to ...more  
Comment by dmacd on Apr 08, 2019 6:55pm
PUNT senior management and the BOD. Bigger shareholders need to bring in another team since this one is clearly inept at managing shareholder value. They are running a lifestyle company where they earn a big salary and continue to raise money with no regard for shareholders. These guys would have not lasted in the oil sector. Why are medtech investors are so willing to sponsor such wasteful ...more